Because of its immunosuppressive functions, in vivo administration of IL-10 has been tested in murine models of immune-mediated diseases, including inflammatory bowel disease (IBD), rheumatoid arthritis (RA), and type 1 diabetes, and proved to alleviate the inflammation and the undesired immune response [Reviewed in Ref. This evidence concerns the gene IL10 and rheumatoid arthritis.